Introduction
It is observed that gastric mucosal injure is involved in the upper digestive tract bleeding in the patients with liver cirrhosis and portal hypertension. This kind of gastric mucosal injure is called portal hypertension gastropathy (PHG) [1] . The pathogenesis of PHG includes the impaired protective function of gastric mucosa except for portal hypertension. As it is observed that the permeability of the intestinal barrier increases and toxic substances from the intestine are spread in the liver during PHG, It is presumed that in PHG, the endotoxin from the intestine could induce a lot of factors to destroy the gastric mucosal barrier [2] .But the hypothesis is still short of enough experimental evidence. The current research is to study the presumed role of endotoxin in the gastric mucosal injure during PHG.
Materials and methods
Forty male Wistar rats purchased from an experimental animal center (Chongqing University of Medical Science, China), weighing about 200-250 g, were randomly assigned into four groups: the normal control group (Group A), PHG model group(Group B), PHG model+endotoxin group (Group C), PHG model＋BPI21 group (Group D).
Main reagents
Escherichia coli were from Staff Room of Microbiology, Second Military Medical University, Shanghai, China. Recombinant bactericidal/permeability increasing protein BPI21 was purchased from XOMA Corporation, U.S.A. ELISA kits for tumor necrosis factor alpha (TNF-毩 ) of rats were purchased from Jingmei Biotec. Limited Corporation, Shengzhen,China.
Modeling of liver cirrhosis and PHG
The rats were feed in a standard laboratory for one week before modeling.
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Injection of endotoxin and BPI21
T h e r a t s i n G r o u p C w e r e i n j e c t e d i . p . w i t h lipopolysaccharides (LPS) at 3 mg/kg in the 4th, 6th, 8th week during establishment of PHG model. Meanwhile, animals in Group D were injected by tail vein with BPI21 at 2.0 mg/kg.
Determination of plasma endotoxin and TNF-毩
Endotoxin and TNF-毩 levels in gastric tissue or plasma were measured according to manufacturer's instructions of the kits ( Endotoxin Kit from Yihua Biotech Corp, Shanghai and rat TNF-毩 ELISA Kit from Jinmei Biotech Corp, Shanghai, No.FRK0003). To detect the levels of TNF-毩 protein, gastric tissue samples were homogenized in icecold physiological saline, smashed by ultrasonic, then centrifuged at 3 000 r/min for 10 min at 4 曟 . The supernatant was stored at -70 曟 until analysis.
Histological study
The tissues were embedded in paraffin for blinded histological analysis. Sections were stained with hematoxylin-eosin. Histological scoring was performed in a blind way. The gastric mucosa damage index was calculated as described by Guth et al [3] , which was accumulated by the lesion of erosion, ulcer and bleeding restricted within gastric epithelia. The score's standard is: 0 for normal, 1 for less than 1 mm, 2 for 1-2 mm, etc. Meanwhile, the pathological score of gastric mucosa was counted according to the standard described by Mascuda et al [4] : 0 for normal, 1 for the lesion of surface epithelia, 2 for the surface mucosal hyperemia and edema, 3 for that of middle or bottom layer, 4 for the turbulence or necrosis of mucosal gland, and 5 for the necrosis or ulcer of deep layer.
Statistical analysis
Data were described as mean依SD, and statistical analysis was carried out using SPSS 13.0. Significance was considered at a P < 0.05 level.
Results

Successful modeling of PHG
The liver of the PHG rats appeared filemot, smaller, with big and small nodus on the surface. The portal vein of the model animals became wider and bended. The histological study revealed the occurrence of cirrhosis. Meanwhile, the PHG model rats showed much higher PVP [(17.21依4.72) cmH 2 O vs (8.15依2.80) cmH 2 O, P＜0.01, n=10] and more serious damage in the gastric mucosa, compared with their counterparts in the normal groups, suggesting that PHG model was successfully established (Figure 1 ). Twentythree rats were used as PHG model, including 8 
Changes of the levels of mucosal TNF-毩 and plasma endotoxin during PHG
Compared with the normal rats, PHG rats showed significantly decreased gastric mucosal HSP70, as well as increased mucosal TNF-毩 and plasma endotoxin(P＜0.01), suggesting that HSP70 could act as a protective factor, but TNF-毩 and endotoxin as destructive factors during PHG. (Figure 1 ).
Effects of exogenous endotoxin and BPI21 on the levels of plasma endotoxin and mucosal TNF-毩 in PHG rats
Exogenous endotoxin did not present any effect on the levels of mucosal TNF-毩 in normal rats(P＜0.05), but increased mucosal TNF-毩 in PHG rats(P＜0.01). In PHG rats exogenous endotoxin significantly increased plasma endotoxin, and that BPI21 did not present any effect on the levels of plasma endotoxin, but significantly decreased mucosal TNF-毩 level in PHG rats(P＜0.01), suggesting that endotoxin may be one of the most important pathogenetic factors in PHG (Figure 2 ). 
Effects of exogenous endotoxin and BPI21 on the histological changes of the gastric mucosa
The PHG rats injected with endotoxin induced more serious damage in their gastric mucosa(P＜0.01). PHG rats, the PHG rats injected with LPS show serious damage in their gastric mucosa, including bleeding, edema, erosion, ulcer, as well as the disorganized epithelium, the disappeared gland and abundantly infiltrating inflammatory cells. Contrarily, injection of BPI21 remarkably ameliorate the damage(P＜0.01) (Figure 3, 4) . 
Discussion
The imbalance between the protective and damage factors underlies the gastric mucosal injure during PHG. Endotoxin (potencially from intestine) not only induces abnormal hemodynamics, but also directly damages the mucosa. It is presumed that the endotoxin from intestine may trigger the gastric mucosal damage during PHG. The results show that the endotoxin in the plasma from PHG rats significantly increased, which was consistent with the pathological damage in the gastric mucosa. The endotoxin level in the plasma increased remarkably in both normal and PHG rats injected with endotoxin, but only the latter show more serious mucosal injure. Watanabe et al [5] reported that endotoxin could not hurt the gastric mucosa from normal animals but induce serious injure in the gastric mucosa with venous congestion. These results suggest that exogenous endotoxin could induce the gastric mucosa during PHG. If the dosage continuously increase, the normal rats also show remarkable damage in their gastric mucosa (data not shown).
As a kind of protein universally located in the aniline blue granule within the nutrophilic granulocytes of human and mammal, BPI21 processes high affinity to the lipopolysaccharide molecule of endotoxin and competitively inhibits the contact between endotoxin and its target cell [6] . It is reported that BPI21 can alleviate the systemic inflammatory response induced by endotoxin and fight against the multiple organ dysfunction induced by intestinal endotoxemia/bactearial translocation after shock [7] . In the present study, the pathological performance of the gastric mucosa from PHG rats injected with BPI21 was significantly improved. These results ulteriorly support the concept that endotoxin may be one of the most important pathogenetic factors in PHG. Interestingly, this antagonist of endotoxin can not protect the animals from PHG if PHG has already occurred (data not shown).
The defensive mechanism of gastric mucosa is correlated with the microenvironment in which the epithelia cells are located, including grume layer, cellular regeneration, mucosal blood stream and local compounds and cytokines. TNF-毩 is one of the most important local cytokines, which can induce local inflammation and organ lesion. It is reported that during PHG, TNF-毩 playes a pathogenetic [8] role by regulating the production of ecNOS and prostacyclin. Meanwhile, TNF-毩 can increase the vascular permeability and aggravate the gastric injure [9] . Our results show that compared with their normal counterparts, the levels of the plasma endotoxin and mucosal TNF-毩 significantly increases in the PHG rats, together with the serious damage in the gastric mucosa, suggesting that TNF-毩 may be the major factor in the gastric mucosal injure induced by endotoxin. It remains unclear how endotoxin induces the mucosal expression of TNF-毩 during PHG. In summary, this research shows that endotoxin could exert a pathogenetic role in the damage of the gastric mucosa during PHG, in which the mucosal expression of TNF-毩 may be involved. These results should be beneficial in exploring the novel therapy for the gastric mucosal injure during PHG in clinical practice in the future.
Role of funding source
This work was supported by a Natural Science Foundation of Hainan Province Grant (No. 80599).
